Loading…

Flash Player 9 (or above) is needed to view presentations.
We have detected that you do not have it on your computer. To install it, go here.

Like this document? Why not share!

studylist.doc

on

  • 359 views

 

Statistics

Views

Total Views
359
Views on SlideShare
359
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft Word

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    studylist.doc studylist.doc Document Transcript

    • Adelaide, J., M. Chaffanet, et al. (1998). “Chromosome region 8p11-p21: refined mapping and molecular alterations in breast cancer.” Genes Chromosomes Cancer 22(3): 186-99. Ali, I. U., R. Lidereau, et al. (1989). “Presence of two members of c-erbA receptor gene family (c-erbAbeta and c-erbA2) in smallest region of somatic homozygosity on chromosome 3p21-p25 in human breast carcinoma.” Journal of the National Cancer Institute 81(23): 1815-20. Allione, F., F. Eisinger, et al. (1998). “Loss of heterozygosity at loci from chromosome arm 22Q in human sporadic breast carcinomas.” International Journal of Cancer 75(2): 181-6. An, H. X., A. Claas, et al. (1999). “Two regions of deletion in 9p23-24 in sporadic breast cancer.” Cancer Research 59(16): 3941-3. An, H. X., D. Niederacher, et al. (1996). “Frequent allele loss on 9p21-22 defines a smallest common region in the vicinity of the CDKN2 gene in sporadic breast cancer.” Genes Chromosomes Cancer 17(1): 14-20. Anbazhagan, R., H. Fujii, et al. (1998). “Allelic loss of chromosomal arm 8p in breast cancer progression.” American Journal of Pathology 152(3): 815-9. Andersen, T. I., A. Gaustad, et al. (1992). “Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas.” Genes Chromosomes Cancer 4(2): 113-121. Benachenhou, N., S. Guiral, et al. (1999). “Frequent loss of heterozygosity at the DNA mismatch-repair loci hMLH1 and hMSH3 in sporadic breast cancer.” British Journal of Cancer 79(7-8): 1012-7. Bergthorsson, J. T., J. Johannsdottir, et al. (1998). “Chromosome imbalance at the 3p14 region in human breast tumours: high frequency in patients with inherited predisposition due to BRCA2.” European Journal of Cancer 34(1): 142-7. Bieche, I., M. H. Champeme, et al. (1995). “Loss and gain of distinct regions of chromosome 1q in primary breast cancer.” Clinical Cancer Research 1(1): 123-7. Bieche, I., M. H. Champeme, et al. (1993). “Two distinct regions involved in 1p deletion in human primary breast cancer.” Cancer Research 53(9): 1990-4. Bieche, I., A. Khodja, et al. (1997). “Genetic alteration mapping on chromosome 7 in primary breast cancer.” Clinical Cancer Research 3(6): 1009-16. Bieche, I., A. Khodja, et al. (1998). “Deletion mapping in breast tumor cell lines points to two distinct tumor-suppressor genes in the 1p32-pter region, one of deleted regions (1p36.2) being located within the consensus region of LOH in neuroblastoma.” Oncology Reports 5(1): 267-72. Bieche, I., A. Khodja, et al. (1999). “Deletion mapping of chromosomal region 1p32-pter in primary breast cancer.” Genes Chromosomes Cancer 24(3): 255-63. Borg, A., Q. X. Zhang, et al. (1992). “Chromosome 1 alterations in breast cancer: allelic loss on 1p and 1q is related to lymphogenic metastases and poor prognosis.” Genes Chromosomes Cancer 5(4): 311-20. Bose, S., S. I. Wang, et al. (1998). “Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomas.” Oncogene 17(1): 123-7. Brenner, A. J. and C. M. Aldaz (1995). “Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells.” Cancer Research 55(13): 2892-5. Caldes, T., P. Perez-Segura, et al. (2000). “Low frequency of microsatellite instability in sporadic breast cancer.” International Journal of Oncology 16(6): 1235-42.
    • Caligo, M. A., L. Polidoro, et al. (1998). “A region on the long arm of chromosome 16 is frequently deleted in metastatic node-negative breast cancer.” International Journal of Oncology 13(1): 177-82. Carter, S. L., M. Negrini, et al. (1994). “Loss of heterozygosity at 11q22-q23 in breast cancer.” Cancer Research 54(23): 6270-4. Castells, A., J. F. Gusella, et al. (2000). “A region of deletion on chromosome 22q13 is common to human breast and colorectal cancers.” Cancer Research 60(11): 2836-9. Chalmers, I. J., M. Aubele, et al. (2001). “Mapping the chromosome 16 cadherin gene cluster to a minimal deleted region in ductal breast cancer.” Cancer Genetics and Cytogenetics 126(1): 39-44. Chappell, S. A., T. Walsh, et al. (1997). “Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas.” British Journal of Cancer 75(9): 1324-9. Chen, L. C., C. Dollbaum, et al. (1989). “Loss of heterozygosity on chromosome 1q in human breast cancer.” Proceedings of the National Academy of Sciences, U S A 86(18): 7204-7. Chen, T., A. Sahin, et al. (1996). “Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region.” Cancer Research 56(24): 5605-9. Choi, C., M. H. Kim, et al. (1998). “Loss of heterozygosity on chromosome XP22.2-p22.13 and Xq26.1-q27.1 in human breast carcinomas.” Journal of Korean Medical Science 13(3): 311-6. Chuaqui, R. F., Z. Zhuang, et al. (1997). “Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast.” Am J Pathol 150(1): 297-303. Cleton-Jansen, A. M., D. F. Callen, et al. (2001). “Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions.” Cancer Research 61(3): 1171-7. Cleton-Jansen, A. M., E. W. Moerland, et al. (1994). “At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer.” Genes Chromosomes Cancer 9(2): 101-7. Coles, C., A. M. Thompson, et al. (1990). “Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis.” Lancet 336(8718): 761-3. Cornelis, R. S., P. Devilee, et al. (1993). “Allele loss patterns on chromosome 17q in 109 breast carcinomas indicate at least two distinct target regions.” Oncogene 8(3): 781-5. Cornelis, R. S., M. van Vliet, et al. (1994). “Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.” Cancer Research 54(15): 4200-6. Cropp, C. S., M. H. Champeme, et al. (1993). “Identification of three regions on chromosome 17q in primary human breast carcinomas which are frequently deleted.” Cancer Research 53(23): 5617-9. Dahiya, R., G. Perinchery, et al. (1998). “Multiple sites of loss of heterozygosity on chromosome 8 in human breast cancer has differential correlation with clinical parameters.” International Journal of Oncology 12(4): 811-6. Deng, G., Y. Lu, et al. (1996). “Loss of heterozygosity in normal tissue adjacent to breast carcinomas.” Science 274(5295): 2057-9.
    • Devilee, P., C. J. Cornelisse, et al. (1990). “Loss of heterozygosity on 17p in human breast carcinomas: defining the smallest common region of deletion.” Cytogenetics and Cell Genetics 53(1): 52-4. Devilee, P., M. van den Broek, et al. (1989). “At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma.” Genomics 5(3): 554-60. Devilee, P., M. van Vliet, et al. (1991). “Somatic genetic changes on chromosome 18 in breast carcinomas: is the DCC gene involved?” Oncogene 6(2): 311-5. Dorion-Bonnet, F., S. Mautalen, et al. (1995). “Allelic imbalance study of 16q in human primary breast carcinomas using microsatellite markers.” Genes Chromosomes Cancer 14(3): 171-81. Driouch, K., F. Dorion-Bonnet, et al. (1997). “Loss of heterozygosity on chromosome arm 16q in breast cancer metastases.” Genes Chromosomes Cancer 19(3): 185-91. Eiriksdottir, G., R. B. Barkardottir, et al. (1998). “High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriers.” Oncogene 16(1): 21-6. Eiriksdottir, G., G. Johannesdottir, et al. (1998). “Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis.” European Journal of Cancer 34(13): 2076-81. Eiriksdottir, G., A. Sigurdsson, et al. (1995). “Loss of heterozygosity on chromosome 9 in human breast cancer: association with clinical variables and genetic changes at other chromosome regions.” International Journal of Cancer 64(6): 378-82. Feilotter, H. E., V. Coulon, et al. (1999). “Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma.” British Journal of Cancer 79(5-6): 718-23. Forsti, A., L. Luo, et al. (2001). “Allelic imbalance on chromosomes 13 and 17 and mutation analysis of BRCA1 and BRCA2 genes in monozygotic twins concordant for breast cancer.” Carcinogenesis 22(1): 27-33. Fujii, H., W. Zhou, et al. (1996). “Detection of frequent allelic loss of 6q23-q25.2 in microdissected human breast cancer tissues.” Genes Chromosomes Cancer 16(1): 35-9. Fukino, K., A. Iido, et al. (1999). “Frequent allelic loss at the TOC locus on 17q25.1 in primary breast cancers.” Genes Chromosomes Cancer 24(4): 345-50. Futreal, P. A., P. Soderkvist, et al. (1992). “Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms.” Cancer Research 52(9): 2624-7. Gaki, V., M. Tsopanomichalou, et al. (2000). “Allelic loss in chromosomal region 1q21-23 in breast cancer is associated with peritumoral aniolymphatic invasion and extensive intraductal component.” European Journal of Surgical Oncology 26(5): 455-60. Garcia, J. M., J. M. Silva, et al. (1999). “Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype.” Breast Cancer Research and Treatment 57(3): 237-43. Gentile, M., K. Olsen, et al. (1999). “Frequent allelic losses at 11q24.1-q25 in young women with breast cancer: association with poor survival.” British Journal of Cancer 80(5-6): 843-9. Gentile, M., A. Wiman, et al. (2001). “Deletion mapping of chromosome segment 11q24-25, exhibiting extensive allelic loss in early onset breast cancer.” International Journal of Cancer 92(2): 208-13.
    • Genuardi, M., H. Tsihira, et al. (1989). “Distal deletion of chromosome 1p in ductal carcinoma of the breast.” American Journal of Human Genetics 45(1): 73-82. Gorgoulis, V. G., E. N. Koutroumbi, et al. (1998). “Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomas.” Molecular Medicine 4(12): 807-22. Gudmundsson, J., R. B. Barkardottir, et al. (1995). “Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations.” British Journal of Cancer 72(3): 696-701. Hampton, G. M., A. Mannermaa, et al. (1994). “Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3.” Cancer Research 54(17): 4586-9. Hoggard, N., Y. Hey, et al. (1995). “Identification and cloning in yeast artificial chromosomes of a region of elevated loss of heterozygosity on chromosome 1p31.1 in human breast cancer.” Genomics 30(2): 233-43. Huang, T. H., P. L. Yeh, et al. (1995). “Genetic alterations of microsatellites on chromosome 18 in human breast carcinoma.” Diagnostic Molecular Pathology 4(1): 66-72. Huiping, C., G. Eiriksdottir, et al. (1998). “High frequency of LOH at chromosome 18q in human breast cancer: association with high S-phase fraction and low progesterone receptor content.” Anticancer Research 18(2A): 1031-6. Huiping, C., J. G. Jonasson, et al. (2000). “Analysis of the fragile histidine triad (FHIT) gene in lobular breast cancer.” European Journal of Cancer 36(12): 1552-7. Iida, A., R. Isobe, et al. (1997). “Localization of a breast cancer tumour-suppressor gene to a 3- cM interval within chromosomal region 16q22.” British Journal of Cancer 75(2): 264-7. Iida, A., K. Kurose, et al. (1998). “Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer.” Genes Chromosomes Cancer 21(2): 108-12. Ingvarsson, S., E. K. Geirsdottir, et al. (1998). “High incidence of loss of heterozygosity in breast tumors from carriers of the BRCA2 999del5 mutation.” Cancer Research 58(19): 4421-5. Isomura, M., A. Tanigami, et al. (1994). “Detailed analysis of loss of heterozygosity on chromosome band 17p13 in breast carcinoma on the basis of a high-resolution physical map with 29 markers.” Genes Chromosomes Cancer 9(3): 173-9. Kalikin, L. M., X. Qu, et al. (1996). “Detailed deletion analysis of sporadic breast tumors defines an interstitial region of allelic loss on 17q25.” Genes Chromosomes Cancer 17(1): 64-8. Karnik, P., M. Paris, et al. (1998). “Two distinct tumor suppressor loci within chromosome 11p15 implicated in breast cancer progression and metastasis.” Human Molecular Genetics 7(5): 895-903. Kerangueven, F., F. Allione, et al. (1995). “Patterns of loss of heterozygosity at loci from chromosome arm 13q suggests a possible involvement of BRCA2 in sporadic breast tumors.” Genes Chromosomes Cancer 13(4): 291-4. Kerangueven, F., F. Eisinger, et al. (1997). “Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions.” Oncogene 14(3): 339-47. Kerangueven, F., L. Essioux, et al. (1995). “Loss of heterozygosity and linkage analysis in breast carcinoma: indication for a putative third susceptibility gene on the short arm of chromosome 8.” Oncogene 10(5): 1023-6.
    • Kirchweger, R., R. Zeillinger, et al. (1994). “Patterns of allele losses suggest the existence of five distinct regons of LOH on chromosome 17 in breast cancer.” International Journal of Cancer 56: 193-199. Kittiniyom, K., K. M. Gorse, et al. (2001). “Allelic loss on chromosome band 18p11.3 occurs early and reveals heterogeneity in breast cancer progression.” Breast Cancer Research 3(3): 192-8. Kollias, J., S. Man, et al. (2000). “Loss of heterozygosity in bilateral breast cancer.” Breast Cancer Research and Treatment 64(3): 241-51. Koreth, J., C. J. Bakkenist, et al. (1997). “Allelic deletions at chromosome 11q22-q23.1 and 11q25-qterm are frequent in sporadic breast but not colorectal cancers.” Oncogene 14(4): 431-7. Kristjansson, A. K., G. Eiriksdottir, et al. (1997). “Loss of heterozygosity at chromosome 7q in human breast cancer: association with clinical variables.” Anticancer Research 17(1A): 93-8. Kurose, K., A. Iida, et al. (1998). “Frequent allelic loss at 7p14-15 associated with aggressive histologic types of breast cancer.” Japanese Journal of Cancer Res 89(5): 533-8. Laake, K., V. Launonen, et al. (1999). “Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study. Breast Cancer Somatic Genetics Consortium.” Genes Chromosomes Cancer 25(3): 212-21. Laake, K., A. Odegard, et al. (1997). “Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM.” Genes Chromosomes Cancer 18(3): 175-80. Lakhani, S. R., N. Collins, et al. (1995). “Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p.” Journal of Clinical Pathology 48(7): 611-5. Lichy, J. H., M. Zavar, et al. (1998). “Loss of heterozygosity on chromosome 11p15 during histological progression in microdissected ductal carcinoma of the breast [see comments].” American Journal of Pathology 153(1): 271-8. Lin, J. C., S. W. Scherer, et al. (1996). “Detailed deletion mapping with a refined physical map of 7q31 localizes a putative tumor suppressor gene for breast cancer in the region of MET.” Oncogene 13(9): 2001-8. Lindblom, A., L. Skoog, et al. (1993). “Four separate regions on chromosome 17 show loss of heterozygosity in familial breast carcinomas.” Human Genetics 91(1): 6-12. Lininger, R. A., W. S. Park, et al. (1998). “LOH at 16p13 is a novel chromosomal alteration detected in benign and malignant microdissected papillary neoplasms of the breast.” Human Pathology 29(10): 1113-8. Lininger, R. A., Z. Zhuang, et al. (1999). “Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.” Modern Pathology 12(12): 1083-9. Lo, Y. L., J. C. Yu, et al. (1998). “Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset).” International Journal of Cancer 79(6): 580-7. Loupart, M. L., S. Adams, et al. (1995). “Loss of heterozygosity on the X chromosome in human breast cancer.” Genes Chromosomes Cancer 13(4): 229-38. Loupart, M. L., J. Armour, et al. (1995). “Allelic imbalance on chromosome 1 in human breast cancer. I. Minisatellite and RFLP analysis.” Genes Chromosomes Cancer 12(1): 16-23.
    • Marsh, D. J., P. L. Dahia, et al. (1998). “Allelic imbalance, including deletion of PTEN/MMAC1, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation.” Genes Chromosomes Cancer 21(1): 61-9. Marsh, K. L. and J. M. Varley (1998). “Loss of heterozygosity at chromosome 9p in ductal carcinoma in situ and invasive carcinoma of the breast.” British Journal of Cancer 77(9): 1439-47. Matsumoto, S., F. Kasumi, et al. (1997). “Detailed deletion mapping of chromosome arm 3p in breast cancers: a 2-cM region on 3p14.3-21.1 and a 5-cM region on 3p24.3-25.1 commonly deleted in tumors.” Genes Chromosomes Cancer 20(3): 268-74. Merajver, S. D., T. S. Frank, et al. (1995). “Germline BRCA1 mutations and loss of the wild- type allele in tumors from families with early onset breast and ovarian cancer.” Clinical Cancer Research 1(5): 539-44. Merlo, G. R., J. Siddiqui, et al. (1989). “Frequent alteration of the DF3 tumor-associated antigen gene in primary human breast carcinomas.” Cancer Research 49(24 Pt 1): 6966-71. Minobe, K., M. Onda, et al. (1998). “Allelic loss on chromosome 9q is associated with lymph node metastasis of primary breast cancer.” Japanese Journal of Cancer Research 89(9): 916-22. Nagai, H., M. Negrini, et al. (1995). “Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer.” Cancer Research 55(8): 1752-7. Nagai, M. A., M. M. Pacheco, et al. (1994). “Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients.” British Journal of Cancer 69(4): 754-8. Nagai, M. A., L. Yamamoto, et al. (1994). “Detailed deletion mapping of chromosome segment 17q12-21 in sporadic breast tumours.” Genes Chromosomes Cancer 11(1): 58-62. Nakata, T., M. Yoshimoto, et al. (1998). “Identification of a new commonly deleted region within a 2-cM interval of chromosome 11p11 in breast cancers.” European Journal of Cancer 34(3): 417-21. Negrini, M., D. Rasio, et al. (1995). “Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3.” Cancer Research 55(14): 3003-7. Niederacher, D., F. Picard, et al. (1997). “Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis.” Genes Chromosomes Cancer 18(3): 181-92. Noviello, C., F. Courjal, et al. (1996). “Loss of heterozygosity on the long arm of chromosome 6 in breast cancer: possibly four regions of deletion.” Clinical Cancer Research 2(9): 1601-6. O'Connell, P., K. Fischbach, et al. (1999). “Loss of heterozygosity at D14S62 and metastatic potential of breast cancer [see comments].” Journal of the National Cancer Institute 91(16): 1391-7. Oesterreich, S., D. C. Allredl, et al. (2001). “High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer.” British Journal of Cancer 84(4): 493-8. Ohgaki, K., A. Iida, et al. (1998). “Mapping of a new target region of allelic loss to a 6-cM interval at 21q21 in primary breast cancers.” Genes Chromosomes Cancer 23(3): 244-7. Orphanos, V., G. McGown, et al. (1995). “Proximal 6q, a region showing allele loss in primary breast cancer.” British Journal of Cancer 71(2): 290-3.
    • Osborne, R. J., G. R. Merlo, et al. (1991). “Mutations in the p53 gene in primary human breast cancers.” Cancer Research 51(22): 6194-8. Patel, U., S. Grundfest-Broniatowski, et al. (1994). “Microsatellite instabilities at five chromosomes in primary breast tumors.” Oncogene 9(12): 3695-700. Peng, H., F. Xu, et al. (2000). “ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers.” International Journal of Cancer 86(5): 690-4. Phelan, C. M., A. Borg, et al. (1998). “Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.” Cancer Research 58(5): 1004-12. Phelan, C. M., C. Larsson, et al. (1996). “The human mammary-derived growth inhibitor (MDGI) gene: genomic structure and mutation analysis in human breast tumors.” Genomics 34(1): 63-8. Piao, Z., K. S. Lee, et al. (2001). “Identification of novel deletion regions on chromosome arms 2q and 6p in breast carcinomas by amplotype analysis.” Genes Chromosomes Cancer 30(2): 113-22. Plummer, S. J., M. J. Paris, et al. (1997). “Four regions of allelic imbalance on 17q12-qter associated with high-grade breast tumors.” Genes Chromosomes Cancer 20(4): 354-62. Radford, D. M., K. Fair, et al. (1993). “Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast.” Cancer Research 53(13): 2947-9. Radford, D. M., K. L. Fair, et al. (1995). “Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.” Cancer Research 55(15): 3399-405. Radford, D. M., N. J. Phillips, et al. (1995). “Allelic loss and the progression of breast cancer [published erratum appears in Cancer Res 1996 Feb 15;56(4):935].” Cancer Research 55(22): 5180-3. Ragnarsson, G., G. Eiriksdottir, et al. (1999). “Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival.” British Journal of Cancer 79(9-10): 1468-74. Rouba, A., N. Kaisi, et al. (2000). “Patterns of allelic loss at the BRCA1 locus in Arabic women with breast cancer.” International Journal of Molecular Medicine 6(5): 565-9. Saito, H., J. Inazawa, et al. (1993). “Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors.” Cancer Research 53(14): 3382-5. Sato, T., F. Akiyama, et al. (1991). “Accumulation of genetic alterations and progression of primary breast cancer.” Cancer Research 51(21): 5794-9. Sato, T., A. Tanigami, et al. (1990). “Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.” Cancer Research 50(22): 7184-9. Schildkraut, J. M., N. K. Collins, et al. (1995). “Loss of heterozygosity on chromosome 17q11-21 in cancers of women who have both breast and ovarian cancer.” American Journal of Obstetrics and Gynecology 172(3): 908-13. Seitz, S., K. Rohde, et al. (1997). “Deletion mapping and linkage analysis provide strong indication for the involvement of the human chromosome region 8p12-p22 in breast carcinogenesis.” British Journal of Cancer 76(8): 983-91. Seitz, S., S. Werner, et al. (2000). “Refined deletion mapping in sporadic breast cancer at chromosomal region 8p12-p21 and association with clinicopathological parameters.” European Journal of Cancer 36(12): 1507-13.
    • Shen, C. Y., J. C. Yu, et al. (2000). “Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.” Cancer Research 60(14): 3884-92. Sheng, Z. M., A. Marchetti, et al. (1996). “Multiple regions of chromosome 6q affected by loss of heterozygosity in primary human breast carcinomas.” British Journal of Cancer 73(2): 144-7. Shivapurkar, N., S. Sood, et al. (1999). “Multiple regions of chromosome 4 demonstrating allelic losses in breast carcinomas.” Cancer Research 59(15): 3576-80. Sigbjornsdottir, B. I., G. Ragnarsson, et al. (2000). “Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer.” Journal of Medical Genetics 37(5): 342-7. Silva, J. M., R. Gonzalez, et al. (1999). “Loss of heterozygosity in BRCA1 and BRCA2 markers and high-grade malignancy in breast cancer.” Breast Cancer Research and Treatment 53(1): 9-17. Singh, B., M. M. Ittmann, et al. (1998). “Sporadic breast cancers exhibit loss of heterozygosity on chromosome segment 10q23 close to the Cowden disease locus.” Genes Chromosomes Cancer 21(2): 166-71. Skirnisdottir, S., G. Eiriksdottir, et al. (1995). “High frequency of allelic imbalance at chromosome region 16q22-23 in human breast cancer: correlation with high PgR and low S phase.” International Journal of Cancer 64(2): 112-6. Sourvinos, G., H. Kiaris, et al. (1997). “Microsatellite instability and loss of heterozygosity in primary breast tumours.” Tumour Biology 18(3): 157-66. Spirin, K. S., J. F. Simpson, et al. (1996). “p27/Kip1 mutation found in breast cancer.” Cancer Research 56(10): 2400-2404. Stack, M., D. Jones, et al. (1995). “Detailed mapping and loss of heterozygosity analysis suggests a suppressor locus involved in sporadic breast cancer within a distal region of chromosome band 17p13.3.” Human Molecular Genetics 4(11): 2047-55. Suzuki, A., X. Shao, et al. (1999). “Identification of a 5-cM region of common allelic loss on 8p12-p21 in human breast cancer and genomic analysis of the hEXT1L/EXTR1/EXTL3 gene in this locus.” International Journal of Oncology 15(3): 443-51. Theile, M., S. Seitz, et al. (1996). “A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer.” Oncogene 13(4): 677-85. Thorlacius, S., A. L. Borresen, et al. (1993). “Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor.” Cancer Research 53(7): 1637-41. Tomlinson, I. P., H. Nicolai, et al. (1996). “The frequency and mechanism of loss of heterozygosity on chromosome 11q in breast cancer.” Journal of Pathology 180(1): 38-43. Tomlinson, I. P., J. E. Strickland, et al. (1995). “Loss of heterozygosity on chromosome 11 q in breast cancer.” Journal of Clinical Pathology 48(5): 424-8. Tsuda, H., D. F. Callen, et al. (1994). “Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread.” Cancer Research 54(2): 513-7. Tsuda, H., T. Takarabe, et al. (2001). “Pattern of chromosome 16q loss differs between an atypical prolierative lesion and an intraductal or invasive ductal carcinoma occurring subsequently in the same area of the breast.” Modern Pathology 14(5): 382-8.
    • Tsukamoto, K., N. Ito, et al. (1998). “Allelic loss on chromosome 1p is associated with progression and lymph node metastasis of primary breast carcinoma.” Cancer 82(2): 317-22. Utada, Y., S. Haga, et al. (2000). “Mapping of target regions of allelic loss in primary breast cancers to 1-cM intervals on genomic contigs at 6q21 and 6q25.3.” Japanese Journal of Cancer Research 91(3): 293-300. van den Berg, J., O. Johannsson, et al. (1996). “Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer.” British Journal of Cancer 74(10): 1615-9. Varley, J. M., W. J. Brammar, et al. (1991). “Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas.” Oncogene 6(3): 413-21. Wang, J. C., D. M. Radford, et al. (1999). “Sequence-ready contig for the 1.4-cM ductal carcinoma in situ loss of heterozygosity region on chromosome 8p22-p23.” Genomics 60(1): 1-11. Winqvist, R., G. M. Hampton, et al. (1995). “Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis.” Cancer Research 55(12): 2660-4. Yaremko, M. L., W. M. Recant, et al. (1995). “Loss of heterozygosity from the short arm of chromosome 8 is an early event in breast cancers.” Genes Chromosomes Cancer 13(3): 186-91. Yokota, T., S. Matsumoto, et al. (1997). “Mapping of a breast cancer tumor suppressor gene locus to a 4-cM interval on chromosome 18q21.” Japanese Journal of Cancer Research 88(10): 959-64. Yokota, T., M. Yoshimoto, et al. (1999). “Localization of a tumor suppressor gene associated with the progression of human breast carcinoma within a 1-cM interval of 8p22-p23.1.” Cancer 85(2): 447-52. Zekri, A. R., A. A. Bahnassi, et al. (1999). “Allelic instability as a predictor of survival in Egyptian breast cancer patients.” International Journal of Oncology 15(4): 757-67. Zelada-Hedman, M., M. Torroella, et al. (1994). “Loss of heterozygosity studies in tumors from families with breast-ovarian cancer syndrome.” Human Genetics 94(3): 231-4. Zeng, W. R., P. Watson, et al. (1999). “Refined mapping of the region of loss of heterozygosity on the long arm of chromosome 7 in human breast cancer defines the location of a second tumor suppressor gene at 7q22 in the region of the CUTL1 gene.” Oncogene 18(11): 2015-21. Zenklusen, J. C., I. Bieche, et al. (1994). “(C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer.” Proceedings of the National Academy of Sciences, U S A 91(25): 12155-8.